373 related articles for article (PubMed ID: 31238901)
41. Diagnostic accuracy of interleukin-22 and adenosine deaminase for tuberculous pleural effusions.
He J; Zhang R; Shen Y; Wan C; Zeng N; Qin J; Tian P; Chen L
Curr Res Transl Med; 2018 Nov; 66(4):103-106. PubMed ID: 30217555
[TBL] [Abstract][Full Text] [Related]
42. Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
Lee J; Lee YD; Lim JK; Lee DH; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2017 Aug; 354(2):125-130. PubMed ID: 28864369
[TBL] [Abstract][Full Text] [Related]
43. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
[TBL] [Abstract][Full Text] [Related]
44. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
45. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
Ogawa K; Koga H; Hirakata Y; Tomono K; Tashiro T; Kohno S
Tuber Lung Dis; 1997; 78(1):29-34. PubMed ID: 9666960
[TBL] [Abstract][Full Text] [Related]
46. High IL-35 pleural expression in patients with tuberculous pleural effusion.
Dong X; Yang J
Med Sci Monit; 2015 May; 21():1261-8. PubMed ID: 25935866
[TBL] [Abstract][Full Text] [Related]
47. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
48. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
49. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
50. A novel biomarker for pleural effusion diagnosis: Interleukin-36γ in pleural fluid.
Guo L; Zhang Q; Lv C; Ma X; Song X; Huang J; Chen W; Li C; Ding Q
J Clin Lab Anal; 2023 Jan; 37(1):e24799. PubMed ID: 36478612
[TBL] [Abstract][Full Text] [Related]
51. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
Orphanidou D; Gaga M; Rasidakis A; Dimakou K; Toumbis M; Latsi P; Pandalos J; Christacopoulou J; Jordanoglou J
Respir Med; 1996 Feb; 90(2):95-8. PubMed ID: 8730328
[TBL] [Abstract][Full Text] [Related]
52. [Early secretory antigenic target protein-6/culture filtrate protein-10 fusion protein-specific Th1 and Th2 response and its diagnostic value in tuberculous pleural effusion].
Ge QP; He ZY; Gao WW; DU FJ; Wei PJ; Jia HY; Ma Y; Zhang ZD
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):406-10. PubMed ID: 24103202
[TBL] [Abstract][Full Text] [Related]
53. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
[TBL] [Abstract][Full Text] [Related]
54. Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusion.
Gao Y; Ou Q; Wu J; Zhang B; Shen L; Chen S; Weng X; Zhang Y; Zhang W; Shao L
Sci Rep; 2016 Feb; 6():20607. PubMed ID: 26864868
[TBL] [Abstract][Full Text] [Related]
55. [Values of TNF, IL-8, sICAM-1 and CD11b/CD18 in benign and malignant pleural effusions].
Huang Y; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):35-9. PubMed ID: 11802937
[TBL] [Abstract][Full Text] [Related]
56. [Evaluation of the diagnostic value of adenosine deaminase activity in tuberculous pleuritis].
Yu YX; Tong ZH; Gong JN; Wang Z; Wang XJ; Xu LL; Wu YB; Li HJ; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):273-5. PubMed ID: 20646458
[TBL] [Abstract][Full Text] [Related]
57. Activated partial thromboplastin time as a potential biomarker for the diagnosis of tuberculous pleural effusion.
Liang L; Li X; Liu B; Zhang Q; He X; Tan K; Rong F
Am J Med Sci; 2023 May; 365(5):437-442. PubMed ID: 36283425
[TBL] [Abstract][Full Text] [Related]
58. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy.
Valdés L; San José E; Alvarez D; Valle JM
Eur Respir J; 1996 Apr; 9(4):747-51. PubMed ID: 8726940
[TBL] [Abstract][Full Text] [Related]
59. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion.
Hiraki A; Aoe K; Matsuo K; Murakami K; Murakami T; Onoda T; Sugi K; Takeyama H; Eda R
Int J Tuberc Lung Dis; 2003 Dec; 7(12):1172-7. PubMed ID: 14677892
[TBL] [Abstract][Full Text] [Related]
60. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
